Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)
Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases.
University Hospital, Brest
150 participants
Dec 1, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this multicenter retrospective observational study is to provide an inventory of the specific and non specific cord vocal lesions that can cause dysphonia in patients with systemic autoimmune diseases. The main question it aims to answer is: * What are the main cord vocal lesions responsible for dysphonia in patients with a systemic autoimmune disease? * Is there a diagnosis delay regarding those lesions? * How are those lesions managed? Participants suffering from dysphonia in a context of a systemic autoimmune disease will be identified, with a review of their medical record.
Eligibility
Inclusion Criteria4
- Patients aged 18 years or older
- With a systemic autoimmune disease : rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, primary Sjogren disease, sarcoidosis, vasculitis, myositis, Still disease, Sharp syndrome.
- Suffering from dysphonia.
- With a cord vocal/laryngeal lesion highlighted.
Exclusion Criteria8
- Patients under the age of 18 years
- Dysphonia due to a cord vocal palsy related to a neurological condition or malignancy
- History of cervical radiation
- History of oro-tracheal intubation
- Laryngeal cancer
- Participation deny
- Impossibility of consent
- Patients with legal protection
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06779799